Oxatomide

Oxatomide Structure
Oxatomide structure
Common Name Oxatomide
CAS Number 60607-34-3 Molecular Weight 426.55300
Density 1.175 g/cm3 Boiling Point 621.1ºC at 760 mmHg
Molecular Formula C27H30N4O Melting Point 153.60C
MSDS Chinese USA Flash Point 329.4ºC
Symbol GHS07
GHS07
Signal Word Warning

Treatment of allergic rhinitis in infants and children: efficacy and safety of second-generation antihistamines and the leukotriene receptor antagonist montelukast.

Drugs 69(18) , 2541-76, (2009)

Allergic rhinitis (AR) affects a large percentage of paediatric patients. With the wide array of available agents, it has become a challenge to choose the most appropriate treatment for patients. Second-generation antihistamines have become increasingly popul...

Differential thermodynamic driving force of first- and second-generation antihistamines to determine their binding affinity for human H1 receptors.

Biochem. Pharmacol. 91(2) , 231-41, (2014)

Differential binding sites for first- and second-generation antihistamines were indicated on the basis of the crystal structure of human histamine H1 receptors. In this study, we evaluated differences between the thermodynamic driving forces of first- and sec...

Molecular complexes of ketaconazole and oxatomide with p-chloranil: spectroscopic and spectrofluorimetric studies.

Spectrochim. Acta. A. Mol. Biomol. Spectrosc. 79(5) , 1137-44, (2011)

The molecular complexes of the donors ketaconazole (KTZ) and oxatomide (OXA) drugs with 2,3,5,6-tetrachloro-1,4-benzoquinone (p-chloranil, p-CHL) have been investigated spectroscopically (UV-vis, FT-IR and 1H NMR) and spectrofluorimetrically in different solv...

High-performance liquid chromatographic determination of oxatomide and its metabolite and its application to pharmacokinetic study in rat plasma.

Arzneimittelforschung 52(10) , 754-63, (2002)

Oxatomide (CAS 60607-34-3) is an antiallergic agent effective against allergic rhinitis, urticaria, pruritus dermatitis, eczema dermatitis and bronchial asthma. The aim of this study was to establish the method for simultaneously determining oxatomide and its...

Effect of oxatomide, an antiallergic agent, on QT interval in dogs.

Arzneimittelforschung 51(12) , 971-6, (2001)

Oxatomide (CAS 60607-34-3, KW-4354) is an effective antiallergic agent for allergic rhinitis, urticaria, pruritus cutaneous, and eczema/dermatitis, etc. Terfenadine (CAS 50679-08-8) and astemizole (CAS 68844-77-9), antiallergic agents, have been reported to i...

[Atopic dermatitis: role of oxatomide].

Ann. Dermatol. Venereol. 117 Suppl 1 , 15-9, (1990)

Oxatomide is an antiallergic molecule which acts mainly as a calcium blocker. This article is a review of oxatomide treatment in atopic dermatitis patients. First, an overview of oxatomide treatment hypersensitivity reactions in atopic dermatitis and of their...

Severe cholinergic urticaria successfully treated with scopolamine butylbromide in addition to antihistamines.

Clin. Exp. Dermatol. 31(4) , 588-9, (2006)

Solvent effect on the charge transfer complex of oxatomide with 2,3-dichloro-5,6-dicyanobenzoquinone.

Spectrochim. Acta. A. Mol. Biomol. Spectrosc. 65(5) , 1148-53, (2006)

The charge transfer complex (CT-complex) between oxatomide drug and 2,3-dichloro-5,6-dicyanobenzoquinone (DDQ) was studied spectrophotometrically in 10 solvents at different temperatures. The donor oxatomide is found to form stable 1:1 stoichiometric complex ...

The antiallergic drug oxatomide promotes human eosinophil apoptosis and suppresses IL-5-induced eosinophil survival.

J. Allergy Clin. Immunol. 111(3) , 567-72, (2003)

Eosinophils accumulated in sites of allergic inflammation are thought to play a crucial role in the pathogenesis of allergic disorders including asthma, allergic rhinitis, and atopic dermatitis, and tissue eosinophilia is attributable to increased eosinophil ...

The comparison of the efficacy and safety of cetirizine, oxatomide, ketotifen, and a placebo for the treatment of childhood perennial allergic rhinitis.

Ann. Allergy Asthma Immunol. 89(6) , 589-98, (2002)

There has been no study comparing the long-term effects of ketotifen, oxatomide, and cetirizine for the treatment of perennial allergic rhinitis among children.We conducted a study to compare the efficacy of the three agents for the treatment of perennial all...